Author(s): Pingali SR, Haddad RY, Saad A
Background: Multiple myeloma is an uncommon haematological cancer of plasma cells. Improvements in understanding of this disease have lead to drastic changes regarding diagnosis, management and its prognosis.
Objective: The aim of this article is to provide a concise update regarding the current management of myeloma in Australia, and important management issues for general practitioners.
Discussion: With the advent of new treatments, the outcomes of myeloma have changed drastically in the past decade, and it is now a disease that requires long-term monitoring by both haematologists and general practitioners.
Referred From: https://pubmed.ncbi.nlm.nih.gov/30114882/
Author(s): DimopoulosMA, Kiamouris C, Moulopoulos LA
Author(s): Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R
Author(s): Hu K, Yahalom J
Author(s): Yuranga W, Bruno DM
Author(s): http://www
Author(s): Nofsinger YC, Mirza N, Rowan PT, Lanza D, Weinstein G
Author(s): Losa M, Terreni MR, Tresoldi M, Marcatti M, Campi A, et al.
Author(s): Jagadeesan J, Oudit D, Hardwicke J, Shariff Z, McCoubrey G, et al.
Author(s): Sinnott BP, Hatipoglu B, Sarne DH
Author(s): Elias HG, Scott J, Metheny L, Quereshy FA
Author(s): Campo E, Swedlow SH, Harris NL, Pileri S, Stein H, et al.
Author(s): Ozsahin M, Tsang RW, Poortmans P, Belkacemi Y, Bolla M,et al.
Author(s): Yang B, Yu RL, Chi XH, Lu XC
Author(s): Sonneveld P, Schmidt-Wolf IG, van der Holt B, El Jarari L, Bertsch U, et al.
